Apitegromab helps tirzepatide users lose fat while preserving lean mass
A phase 2 trial suggests that blocking myostatin activation may help people taking tirzepatide retain more lean body…
High obesity levels linked to fewer surgical procedures in Americans
Researchers from LSU’s Pennington Biomedical Research Center and collaborating institutions have found that Americans with the highest levels…
Doctors Changed One Thing and Weight Gain Stopped
A new weight management system developed by an endocrinologist transformed how primary care clinics address obesity. In one…
Keeping rebound weight off after stopping GLP-1 drugs
For many, GLP-1 (glucagon-like peptide-1) drugs like tirzepatide and semaglutide offered an ideal solution to diabetes and weight…
People are battling ‘ghost fat’ after losing weight on GLP-1s
Sometimes, seeing isn’t believing. Across the country, Americans are losing weight faster than ever thanks to blockbuster obesity…
GLP-1-based meds linked to fewer heart events in adults with obesity, autoimmune disease
Research Highlights:
Among people with both obesity and an autoimmune disease, those taking GLP-1-based medications had fewer…
Life-changing medicine or beauty hack? How Ozempic came to be seen as both, and why that’s risky
Dr Kimberly Chew, principal clinical psychologist at AO Psychology, which offers counselling and psychotherapy services, said that the…
Data raises questions about long-term effects of GLP-1 therapies
Eos SENOLYTIX says new preclinical findings highlight body composition and healthy aging as the next frontier in obesity medicine. A…
Fast food is crowding out grocery access across the U.S.
A nationwide study reveals how US neighborhoods became increasingly dominated by restaurants and fast-food outlets, leaving millions with…
Pediatric experts reveal the 10 research areas set to shape child health
From gene therapy and AI to vaccines, nutrition, and cancer care, pediatric research leaders outline where the next…
Physical activity protects heart health regardless of weight loss
With obesity now affecting more than 40% of U.S. adults and fueling rising rates of heart disease, a new scientific statement…
Weight loss drugs could widen health inequalities without nutritional support
Drugs such as semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro) are transforming obesity treatment, but without affordable, healthy food and…